Finally, pharmacological targeting of the activity of -glutamyltransferases prevents the breakdown of circulating GSH, reduces tumour cysteine levels and slows tumour growth
Safety data is similarly limited, with the tolerability of creams and long-term effects sparsely analyzed in the literature
Always follow medical guidelines and consult with a healthcare professional for personalized recommendations
There is no cure for it yet
Ben Salem, M., Affes, H., Ksouda, K., Dhouibi, R., Sahnoun, Z., Hammami, S., & Zeghal, K
Practical Implementation for Research Applications For anti-aging and skin rejuvenation research protocols, implementation uses 1-2 mg daily subcutaneous injection with optional combination topical 0.5-1% GHK-Cu serum, running 8-12 week cycles with 4-6 week off periods, repeating cycles 2-3 times per year